Creative Planning
TNGX icon

Creative Planning’s Tango Therapeutics TNGX Stock Holding History

Creative Planning’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
71,351
+18,444
+35% +$456K ﹤0.01% 2005
2026
Q1 		$1.11M Buy
52,907
+11,000
+26% +$153K ﹤0.01% 2373
2025
Q4 		$371K Buy
41,907
+6,663
+19% +$57.4K ﹤0.01% 3091
2025
Q3 		$296K Buy
+35,244
New +$239K ﹤0.01% 3157

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Creative Planning's TNGX Position: Q2 2026 in Review

Creative Planning increased its Tango Therapeutics (TNGX) stake by 35% in Q2 2026, buying an estimated $456K and bringing the position to 71,351 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

Creative Planning first reported a position in TNGX in Q3 2025 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Creative Planning held 71,351 shares of Tango Therapeutics worth $2.23M as of Q2 2026.
  • Creative Planning bought 18,444 Tango Therapeutics shares in Q2 2026, an estimated $456K.
  • Tango Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2005 holding.
  • Creative Planning first reported a position in Tango Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.